Prelude Therapeutics Inc $PRLD

By Microcap Ledger desk · CIK 0001678660

Facts as of Oct 11, 2026, 08:07 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

This page is still filling in. We publish more sections as filings are processed.

Snapshot

Exchange: Nasdaq Global Select Market
Sector: Pharmaceutical Preparations
Headquarters: Wilmington, DE
Fiscal year end: December 31
Shares outstanding: 79,803,485 [10-Q 2026-08-11]
as of 2026-08-06

Sources: [10-K 2026-03-10]

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	$10.28M	−$24.31M	−$37.26M	$26.33M	[10-Q 2026-08-11]
FY ended Dec 2025	$12.14M	−$99.50M	−$56.30M	$35.26M	[10-K 2026-03-10]
FY ended Dec 2024	$7.00M	−$127.17M	−$102.89M	$12.47M	[10-K 2026-03-10]

Quarterly cash burn: −$18.63M
Cash runway Estimate: ~4.2 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2024-11-04	55,035,170	[10-Q 2024-11-06]
2025-03-06	55,154,634	[10-K 2025-03-10]
2025-04-30	56,460,481	[10-Q 2025-05-06]
2025-08-11	56,600,345	[10-Q 2025-08-14]
2025-11-10	62,865,270	[10-Q 2025-11-12]
2026-03-06	63,002,248	[10-K 2026-03-10]
2026-05-07	79,645,307	[10-Q 2026-05-12]
2026-08-06	79,803,485	[10-Q 2026-08-11]

Shelf registration: S-3 filed 2025-12-10; declared effective 2025-12-16 [S-3 2025-12-10]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-03-28. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2025-03-28	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-03-28]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
Date	Insider	Type	Shares	Price	Filing
2026-04-27	Ra Capital Management, L.P.	other	1,407,000	—	[4 2026-04-28]

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-09-10	8-K	Regulation FD disclosure
2026-08-11	10-Q	Quarterly report
2026-08-11	8-K	Results of operations
2026-07-08	13G	Beneficial ownership report (5%+ holder)
2026-06-10	8-K	Shareholder vote results
2026-05-12	10-Q	Quarterly report
2026-05-12	8-K	Results of operations; Regulation FD disclosure
2026-04-29	DEF 14A	Proxy statement
2026-04-28	13G	Beneficial ownership report (5%+ holder)
2026-04-23	13D/A	Beneficial ownership report (5%+ holder)
2026-04-22	13D/A	Beneficial ownership report (5%+ holder)
2026-04-21	8-K	Material agreement entered; Other events

Facts as of Oct 11, 2026, 08:07 AM UTC. Small caps move fast; check the latest filings.